Treatment of Burned Mice With Hyperbaric Oxygen Reduces Mesenteric Bacteria but Not Pulmonary Neutrophil Deposition

Mayer Tenenhaus, John F. Hansbrough, Ramon Zapata Sirvent, Tom Neumann

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

HBO therapy was associated with reduced numbers of mice with MBCs after burn injury and reduced histologic evidence of mucosal damage, but lung myeloperoxidase levels and metabolic acidosis were not affected. HBO therapy may increase oxygen delivery to ischemic intestine and improve cellular metabolism; alternatively, increased tissue oxygen may augment killing of translocated bacteria by phagocytic cells. HBO deserves further investigation for burn treatment, but because of the narrow therapeutic window and continued neutrophil sequestration in the lungs, we should proceed cautiously. (Arch Surg. 1994;129:1338-1342).

Original languageEnglish (US)
Pages (from-to)1338-1342
Number of pages5
JournalArchives of Surgery
Volume129
Issue number12
DOIs
StatePublished - Jan 1 1994
Externally publishedYes

Fingerprint

Neutrophils
Oxygen
Bacteria
Lung
Phagocytes
Acidosis
Peroxidase
Intestines
Therapeutics
Wounds and Injuries

ASJC Scopus subject areas

  • Surgery

Cite this

Treatment of Burned Mice With Hyperbaric Oxygen Reduces Mesenteric Bacteria but Not Pulmonary Neutrophil Deposition. / Tenenhaus, Mayer; Hansbrough, John F.; Zapata Sirvent, Ramon; Neumann, Tom.

In: Archives of Surgery, Vol. 129, No. 12, 01.01.1994, p. 1338-1342.

Research output: Contribution to journalArticle

@article{36ce0030766043ba82db5f29428f1159,
title = "Treatment of Burned Mice With Hyperbaric Oxygen Reduces Mesenteric Bacteria but Not Pulmonary Neutrophil Deposition",
abstract = "HBO therapy was associated with reduced numbers of mice with MBCs after burn injury and reduced histologic evidence of mucosal damage, but lung myeloperoxidase levels and metabolic acidosis were not affected. HBO therapy may increase oxygen delivery to ischemic intestine and improve cellular metabolism; alternatively, increased tissue oxygen may augment killing of translocated bacteria by phagocytic cells. HBO deserves further investigation for burn treatment, but because of the narrow therapeutic window and continued neutrophil sequestration in the lungs, we should proceed cautiously. (Arch Surg. 1994;129:1338-1342).",
author = "Mayer Tenenhaus and Hansbrough, {John F.} and {Zapata Sirvent}, Ramon and Tom Neumann",
year = "1994",
month = "1",
day = "1",
doi = "10.1001/archsurg.1994.01420360128018",
language = "English (US)",
volume = "129",
pages = "1338--1342",
journal = "JAMA Surgery",
issn = "2168-6254",
publisher = "American Medical Association",
number = "12",

}

TY - JOUR

T1 - Treatment of Burned Mice With Hyperbaric Oxygen Reduces Mesenteric Bacteria but Not Pulmonary Neutrophil Deposition

AU - Tenenhaus, Mayer

AU - Hansbrough, John F.

AU - Zapata Sirvent, Ramon

AU - Neumann, Tom

PY - 1994/1/1

Y1 - 1994/1/1

N2 - HBO therapy was associated with reduced numbers of mice with MBCs after burn injury and reduced histologic evidence of mucosal damage, but lung myeloperoxidase levels and metabolic acidosis were not affected. HBO therapy may increase oxygen delivery to ischemic intestine and improve cellular metabolism; alternatively, increased tissue oxygen may augment killing of translocated bacteria by phagocytic cells. HBO deserves further investigation for burn treatment, but because of the narrow therapeutic window and continued neutrophil sequestration in the lungs, we should proceed cautiously. (Arch Surg. 1994;129:1338-1342).

AB - HBO therapy was associated with reduced numbers of mice with MBCs after burn injury and reduced histologic evidence of mucosal damage, but lung myeloperoxidase levels and metabolic acidosis were not affected. HBO therapy may increase oxygen delivery to ischemic intestine and improve cellular metabolism; alternatively, increased tissue oxygen may augment killing of translocated bacteria by phagocytic cells. HBO deserves further investigation for burn treatment, but because of the narrow therapeutic window and continued neutrophil sequestration in the lungs, we should proceed cautiously. (Arch Surg. 1994;129:1338-1342).

UR - http://www.scopus.com/inward/record.url?scp=0027967927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027967927&partnerID=8YFLogxK

U2 - 10.1001/archsurg.1994.01420360128018

DO - 10.1001/archsurg.1994.01420360128018

M3 - Article

C2 - 7986166

AN - SCOPUS:0027967927

VL - 129

SP - 1338

EP - 1342

JO - JAMA Surgery

JF - JAMA Surgery

SN - 2168-6254

IS - 12

ER -